Alnylam Pharmaceuticals, Inc. (ALNY)
325.07
-7.85
(-2.36%)
USD |
NASDAQ |
Mar 02, 16:00
321.34
-3.73
(-1.15%)
After-Hours: 07:28
Alnylam Pharmaceuticals Total Assets (Quarterly) : 5.026B for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Insmed, Inc. | 2.265B |
| Biogen, Inc. | 29.44B |
| Pfizer Inc. | 208.16B |
| Eli Lilly & Co. | 112.48B |
| AbbVie, Inc. | 133.96B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.236B |
| Shareholders Equity (Quarterly) | 789.18M |
| Debt to Equity Ratio | 3.762 |
| Current Ratio | 2.762 |
| Net Debt Paydown Yield | -0.09% |